Conference Coverage

Here's a walkthrough of some of the most compelling stories coming out of the year's biggest HIV science meeting to date.

A recent analysis conducted by the AIDS Treatment Activists Coalition revealed that, among HIV drug trial participants, data specific to race and sex were dramatically underreported.

Injectable HIV interventions are a game-changing new option for people dealing with pill fatigue, but there are implementation challenges for clinicians to consider.

David Alain Wohl, M.D., on new findings from CROI 2021 that help us better understand the connections between sleep, diet, and quality of life among people living with HIV.

The incidence of anal cancer is rapidly growing in the United States, and may overtake cervical cancer within the next 10 years.

Our bite-sized study summaries include new research on antiretrovirals in development, trends in antiretroviral initiation speed and viral suppression rates in the U.S., and the link between gender-affirming surgery and an undetectable viral load.

There's new research on the risk of severe COVID-19 among people living with HIV, as well as prevention and treatment options.

For the first time, the influential annual CROI was going to postpone making its ample data available to the public. But the global HIV community swiftly protested.

Newly reported research includes deep dives into many health issues commonly experienced by people living with HIV, including cancer, cardiovascular disease, depression/anxiety, and metabolic disorders.

Arriving on the one-year anniversary of nationwide COVID-19 shutdowns, the 2021 Conference on Retroviruses and Opportunistic Infections won't be in person this year—but it will emphasize COVID-19 alongside important HIV prevention and treatment updates.